| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/DMRR.1275 |
| P8608 | Fatcat ID | release_nssjjm7w7fbpfiu6dyfjdkwjoe |
| P698 | PubMed publication ID | 22069288 |
| P50 | author | Chantal Mathieu | Q54656098 |
| Lut Overbergh | Q92483088 | ||
| Gabriela Bomfim Ferreira | Q113940295 | ||
| P2093 | author name string | Conny Gysemans | |
| Mark Waer | |||
| Annemieke Verstuyf | |||
| Evelyne van Etten | |||
| P2860 | cites work | Duodenal calcium absorption in vitamin D receptor-knockout mice: functional and molecular aspects | Q24555101 |
| Defective CD4+CD25+ regulatory T cell functioning in collagen-induced arthritis: an important factor in pathogenesis, counter-regulated by endogenous IFN-gamma | Q24804229 | ||
| A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding | Q25938984 | ||
| Unique regulation of CCL18 production by maturing dendritic cells | Q28185014 | ||
| DCs metabolize sunlight-induced vitamin D3 to 'program' T cell attraction to the epidermal chemokine CCL27 | Q28285583 | ||
| 1 Alpha,25-dihydroxyvitamin D3 inhibits differentiation, maturation, activation, and survival of dendritic cells leading to impaired alloreactive T cell activation | Q28370605 | ||
| Dendritic cells: specialized and regulated antigen processing machines | Q29617085 | ||
| Tolerogenic dendritic cells | Q29618755 | ||
| Regulation of dendritic cell trafficking: a process that involves the participation of selective chemokines | Q33712280 | ||
| Chemokines and dendritic cell traffic. | Q34002668 | ||
| Vitamin D: modulator of the immune system. | Q34112707 | ||
| Regulatory T cells induced by 1 alpha,25-dihydroxyvitamin D3 and mycophenolate mofetil treatment mediate transplantation tolerance. | Q34516841 | ||
| Generation of dendritic cell-based vaccines for cancer therapy | Q34708252 | ||
| Immature, but not inactive: the tolerogenic function of immature dendritic cells | Q34842360 | ||
| Anti-CD3 antibody induces long-term remission of overt autoimmunity in nonobese diabetic mice | Q34904815 | ||
| Dendritic cell regulation of immune responses: a new role for interleukin 2 at the intersection of innate and adaptive immunity | Q35139530 | ||
| Dendritic cells: regulators of alloimmunity and opportunities for tolerance induction | Q35583516 | ||
| Dendritic cells and autoimmunity | Q35756961 | ||
| Dendritic cell immunotherapy: mapping the way. | Q35762464 | ||
| Immunoregulation by 1,25-dihydroxyvitamin D3: basic concepts | Q36208185 | ||
| Dendritic cell modulation by 1alpha,25 dihydroxyvitamin D3 and its analogs: a vitamin D receptor-dependent pathway that promotes a persistent state of immaturity in vitro and in vivo | Q36236655 | ||
| In vitro generation of interleukin 10-producing regulatory CD4(+) T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Th1)- and Th2-inducing cytokines. | Q36370315 | ||
| Regulatory dendritic cell therapy in organ transplantation | Q36501663 | ||
| Roles for accessory molecules in microbial recognition by Toll-like receptors | Q36585990 | ||
| Vitamin D signaling in immune-mediated disorders: Evolving insights and therapeutic opportunities | Q37214071 | ||
| Myeloid dendritic cell: From sentinel of immunity to key player of peripheral tolerance? | Q37393423 | ||
| The effects of combined treatment with the novel vitamin D analogue MC 1288 and cyclosporine A on cardiac allograft survival | Q40973392 | ||
| Autoantigen-specific protection of non-obese diabetic mice from cyclophosphamide-accelerated diabetes by vaccination with dendritic cells | Q42797969 | ||
| 1alpha,25-Dihydroxyvitamin d3 has a direct effect on naive CD4(+) T cells to enhance the development of Th2 cells. | Q43775059 | ||
| 1 alpha,25-Dihydroxycholecalciferol reduces rejection and improves survival in rat liver allografts | Q43779213 | ||
| 1alpha,25-dihydroxyvitamin D3 shows strong and additive immunomodulatory effects with cyclosporine A in rat renal allotransplants | Q43850962 | ||
| Treatment of autoimmune diabetes recurrence in non-obese diabetic mice by mouse interferon-beta in combination with an analogue of 1alpha,25-dihydroxyvitamin-D3. | Q43977137 | ||
| Redirection of human autoreactive T-cells Upon interaction with dendritic cells modulated by TX527, an analog of 1,25 dihydroxyvitamin D(3). | Q44043207 | ||
| Distinctive dendritic cell modulation by vitamin D(3) and glucocorticoid pathways. | Q44148501 | ||
| NOD bone marrow-derived dendritic cells are modulated by analogs of 1,25-dihydroxyvitamin D3. | Q44958298 | ||
| 1,25-Dihydroxyvitamin D3 alters the profile of bone marrow-derived dendritic cells of NOD mice | Q45256436 | ||
| Semi-mature DC are immunogenic and not tolerogenic when inoculated at a high dose in collagen-induced arthritis mice. | Q51567175 | ||
| Prevention of autoimmune destruction of syngeneic islet grafts in spontaneously diabetic nonobese diabetic mice by a combination of a vitamin D3 analog and cyclosporine. | Q52039305 | ||
| Dendritic Cells Matured With TNF can be Further Activated In Vitro and After Subcutaneous Injection In Vivo Which Converts Their Tolerogenicity Into Immunogenicity | Q56689252 | ||
| The vitamin D analog, TX527, promotes a human CD4+CD25highCD127low regulatory T cell profile and induces a migratory signature specific for homing to sites of inflammation | Q56899188 | ||
| "Alternatively activated" dendritic cells preferentially secrete IL-10, expand Foxp3+CD4+ T cells, and induce long-term organ allograft survival in combination with CTLA4-Ig | Q56901846 | ||
| Proteome analysis demonstrates profound alterations in human dendritic cell nature by TX527, an analogue of vitamin D | Q57001218 | ||
| A vitamin D analog, MC1288, inhibits adventitial inflammation and suppresses intimal lesions in rat aortic allografts | Q73251435 | ||
| Vitamin D3 affects differentiation, maturation, and function of human monocyte-derived dendritic cells | Q73709030 | ||
| Blockade of the CD40-CD40 ligand pathway potentiates the capacity of donor-derived dendritic cell progenitors to induce long-term cardiac allograft survival | Q74015557 | ||
| 1alpha,25-dihydroxyvitamin D3 induces an autoantigen-specific T-helper 1/T-helper 2 immune shift in NOD mice immunized with GAD65 (p524-543) | Q74102311 | ||
| 1alpha,25-dihydroxyvitamin D3 or analogue treated dendritic cells modulate human autoreactive T cells via the selective induction of apoptosis | Q80900211 | ||
| P433 | issue | 8 | |
| P921 | main subject | dendritic cell | Q506253 |
| P304 | page(s) | 933-941 | |
| P577 | publication date | 2011-11-01 | |
| P1433 | published in | Diabetes - Metabolism: Research and Reviews | Q15750056 |
| P1476 | title | 1,25-Dihydroxyvitamin D3 alters murine dendritic cell behaviour in vitro and in vivo. | |
| P478 | volume | 27 |
| Q40572871 | 1,25 Dihydroxyvitamin D circulating levels, calcitriol administration, and incidence of acute rejection, CMV infection, and polyoma virus infection in renal transplant recipients |
| Q47130256 | 1,25-Dihydroxyvitamin D3 modulates the phenotype and function of Monocyte derived dendritic cells in cattle. |
| Q36292610 | 1,25-Dihydroxyvitamin D3-Conditioned CD11c+ Dendritic Cells are Effective Initiators of CNS Autoimmune Disease. |
| Q50447257 | 1,25-dihydroxyvitamin D3 regulates the development of chronic colitis by modulating both T helper (Th)1 and Th17 activation. |
| Q36494694 | Active vitamin D (1,25-dihydroxyvitamin D3) increases host susceptibility to Citrobacter rodentium by suppressing mucosal Th17 responses |
| Q36104165 | Allostimulatory Effects of Dendritic Cells with Characteristic Features of a Regulatory Phenotype. |
| Q51034724 | Beneficial effect of tolerogenic dendritic cells pulsed with MOG autoantigen in experimental autoimmune encephalomyelitis. |
| Q35154069 | Change in vitamin d levels occurs early after antiretroviral therapy initiation and depends on treatment regimen in resource-limited settings |
| Q34081850 | Circulating levels of 25-hydroxyvitamin D and acute cellular rejection in kidney allograft recipients |
| Q36237164 | Dietary vitamin D3 deficiency alters intestinal mucosal defense and increases susceptibility to Citrobacter rodentium-induced colitis |
| Q26739998 | Effects of Adoptive Transfer of Tolerogenic Dendritic Cells on Allograft Survival in Organ Transplantation Models: An Overview of Systematic Reviews |
| Q38047405 | Effects of vitamin D on antigen-specific and non-antigen-specific immune modulation: relevance for type 1 diabetes |
| Q40354703 | Evidence for the Importance of Vitamin D Status in Neurologic Conditions. |
| Q26779413 | Gene Expression Profiling of Human Monocyte-derived Dendritic Cells - Searching for Molecular Regulators of Tolerogenicity |
| Q26764855 | Generation of Tolerogenic Dendritic Cells and Their Therapeutic Applications |
| Q38842023 | Inflammation, vitamin D and dendritic cell precursors in chronic kidney disease. |
| Q90079848 | Influence of Vitamin D on Islet Autoimmunity and Beta-Cell Function in Type 1 Diabetes |
| Q64228068 | Intranasal Treatment With 1, 25-Dihydroxyvitamin D3 Alleviates Allergic Rhinitis Symptoms in a Mouse Model |
| Q39030292 | Metabolites: deciphering the molecular language between DCs and their environment. |
| Q38718929 | Prevention and treatment of cancers by immune modulating nutrients. |
| Q53410727 | Proinsulin multi-peptide immunotherapy induces antigen-specific regulatory T cells and limits autoimmunity in a humanized model. |
| Q26866216 | Regulatory dendritic cells for immunotherapy in immunologic diseases |
| Q40674036 | Regulatory multitasking of tolerogenic dendritic cells - lessons taken from vitamin d3-treated tolerogenic dendritic cells |
| Q38610901 | Role of vitamin D in cytotoxic T lymphocyte immunity to pathogens and cancer |
| Q26827749 | THERAPY OF ENDOCRINE DISEASE: Islet transplantation for type 1 diabetes: so close and yet so far away |
| Q38672342 | The Active Metabolite of Vitamin D3 as a Potential Immunomodulator |
| Q91808288 | The Role of Vitamin D and Omega-3 PUFAs in Islet Transplantation |
| Q38117282 | Type 1 diabetes therapy beyond T cell targeting: monocytes, B cells, and innate lymphocytes |
| Q38979293 | Vitamin D Level Between Calcium-Phosphorus Homeostasis and Immune System: New Perspective in Osteoporosis. |
| Q38181709 | Vitamin D and chronic obstructive pulmonary disease: hype or reality? |
| Q37083785 | Vitamin D and immune function |
| Q37576846 | Vitamin D and the Immune System from the Nephrologist's Viewpoint. |
| Q27011804 | Vitamin D as an Immunomodulator: Risks with Deficiencies and Benefits of Supplementation |
| Q44287414 | Vitamin D controls murine and human plasmacytoid dendritic cell function |
| Q55283531 | Vitamin D in Human Immunodeficiency Virus Infection: Influence on Immunity and Disease. |
| Q50942487 | Vitamin D3 deficiency increases sinus mucosa dendritic cells in pediatric chronic rhinosinusitis with nasal polyps. |
| Q34621641 | Vitamin D: Metabolism, Molecular Mechanism of Action, and Pleiotropic Effects. |
Search more.